Since most of the mutations identified alter the adaptive rather than the innate immune signaling, we conclude that the presence of T and B/plasma cell subpopulations in close proximity to CD34+ blasts in MDS and sAML is independent of the mutation induced neoantigens associated with immune modulatory mechanisms [34,46]. The gene discussed is CD34; the disease is myelodysplastic syndrome.